Literature DB >> 23905621

Fundus autofluorescence imaging in hereditary ATTR amyloidosis with ocular involvement.

Chiara Veronese1, Eleonora B Marcheggiani, Filippo Tassi, Ilaria Gallelli, Grayson W Armstrong, Antonio P Ciardella.   

Abstract

UNLABELLED: Fundus autofluorescence (AF) is a non-invasive technique for the evaluation of intrinsic autofluorescence of the tissues within the eye. In recent years, autofluorescence has become an important diagnostic tool for the assessment of various ocular diseases. A previous study has found that ex vivo Aβ amyloid plaques in the retina of a transgenic mouse model appear hyper-autofluorescent (hyper-AF) under specific wavelengths (excitation at 830 nm, emission at 630). We report the first description of hyper-AF ocular findings in a case of transthyretin-related familial amyloid polyneuropathy (FAP) associated with ocular involvement using AF imaging. A 47-year-old woman from Italy presented to our institution with a history of early onset FAP with ocular involvement due to the rare amyloidogenic transthyretin Glu54Lys mutation. AF imaging showed hyper-AF amyloid deposits associated with retinal vessels in both eyes and a hyper-AF amyloid deposit anterior to the optic disk in the right eye. CONCLUSION AND RELEVANCE: Further studies in FAP patients with different types of genetic mutations and various disease-stages are needed to better establish if non-invasive AF imaging is useful in detecting ocular amyloidosis.

Entities:  

Mesh:

Year:  2013        PMID: 23905621     DOI: 10.3109/13506129.2013.823082

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  2 in total

Review 1.  Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives.

Authors:  João Heitor Marques; João Coelho; Maria João Menéres; João Melo Beirão
Journal:  Clin Ophthalmol       Date:  2022-07-09

2.  Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Alexander Nørgård Alsing; Jonas Ellegaard Nielsen; Shona Pedersen; Svend Kirkeby; Bent Honoré; Henrik Vorum
Journal:  Mol Vis       Date:  2018-11-26       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.